<- Go Home

Craneware plc

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. It provides solutions, such as Trisus Pricing Analyzer and Transparency, a solution that optimizes and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity requirements; Trisus Claims Informatics, a retrospective charge capture analytical application; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit solution for government and commercial payors. The company also offers Trisus Decision Support; Trisus Labor Productivity, which enables healthcare providers to manage, analyze, and plan the deployment of workforce; Trisus Medication Analytic solutions that prioritize, diagnose, and resolve issues in medication systems; and Trisus Supplies Assistant solutions which supplies charged data. In addition, it provides Sentrex, a SaaS-based solution that helps covered entities expand medication access; Sentinel, that tracks all drug activity; Referral Verification System; and Central Pharmacy Distribution, a centralized purchasing application. Further, the company offers professional, pharmacy professional, and appeal services. Additionally, the company provides The Academy, an interactive learning center for user training; Trisus Pricing Integrity Suite; Trisus Business of Pharmacy Suite, which offers solutions centered on each link in the medication revenue cycle; Trisus Value-based Margin and Productivity Suite; and Trisus Data Integrity Suite, which creates a proactive workflow that aligns data between operating units, the supply chain and revenue cycle. Craneware plc was incorporated in 1999 and is headquartered in Edinburgh, the United Kingdom.

Market Cap

GBP 613.1M

Volume

91.7K

Cash and Equivalents

GBP 40.9M

EBITDA

GBP 30.0M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

GBP 182.1M

Profit Margin

86.15%

52 Week High

GBP 35.71

52 Week Low

GBP 13.34

Dividend

2.50%

Price / Book Value

1.87

Price / Earnings

28.82

Price / Tangible Book Value

-8.59

Enterprise Value

GBP 599.1M

Enterprise Value / EBITDA

19.46

Operating Income

GBP 27.8M

Return on Equity

6.72%

Return on Assets

3.18

Cash and Short Term Investments

GBP 40.9M

Debt

GBP 26.9M

Equity

GBP 339.4M

Revenue

GBP 211.3M

Unlevered FCF

-GBP 2.2M

Sector

Health Care Technology

Category

N/A

Company Stock Pitches